7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
CAS: 72558-82-8
Ref. IN-DA00IKIP
1g | Ausgelaufen | ||
5g | Ausgelaufen | ||
25g | Ausgelaufen | ||
250mg | Ausgelaufen |
Produktinformation
Name:
7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Synonyme:
- [u'Ceftazidime', u'Ceftazidime Anhydrous', u'Ceftazidime Pentahydrate', u'Fortaz', u'Fortum', u'GR 20263', u'GR-20263', u'GR20263', u'LY 139381', u'LY-139381', u'LY139381', u'Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-', u'Tazidime', u'ceftazidime', u'ceftazidima', u'ceftazidimum', u'Fortaz', u'72558-82-8', u'Pentacef', u'Tazicef', u'Tazidime', u'Ceptaz', u'Fortum', u'Ceftazidime anhydrous', u'CHEBI:3508', u'Tazidime In Plastic Container', u'Fortaz (TN)', u'GR 20263', u'C22H22N6O7S2', u'Fortaz In Plastic Container', u'Ceftazidime (INN)', u'Ceftazidime Sodium In Plastic Container', u'CAZ', u'Ceftazidimum [INN-Latin]', u'Ceftazidima [INN-Spanish]', u'Ceftazidim', u'78439-06-2', u'Ceftazidime (TN)', u'Ceptaz (TN)', u'AC1NUK7U', u'SCHEMBL36849', u'BIDD:GT0734', u'CHEMBL44354', u'DTXSID5022770', u'HMS2090M13', u'(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', u'HY-B0593', u'BDBM50420259', u'AKOS015951273', u'CS-2810', u'DB00438', u'AN-37419', u'CEFTAZIDIME (ARGININE FORMULATION)', u'AB1009357', u'AB00513848', u'C06889', u'D07654', u'AB00513848-02', u'Cefprozil, Antibiotic for Culture Media Use Only', u'Q-200811', u'(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', u'(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', u'(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate', u'1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium', u'7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate', u'biotum', u'null', u'Modacin', u'Fortam', u'Tizime', u'Zidim', u'Ceftazidime [INN]', u'Ceftazidime pentahydrate', u'SN 401 pentahydrate', u'GR 20263 pentahydrate', u'UNII-DZR1ENT301', u'UNII-9M416Z9QNR', u'SN 401', u'Ceftazidime [USAN:BAN:INN:JAN]', u'Ceftazidime [USAN:INN:BAN:JAN]', u'C22H22N6O7S2.5H2O', u'EINECS 276-715-9', u'C22-H22-N6-O7-S2', u'CID5481173', u'BRN 4344904', u'Ceftazidime [USAN:USP:INN:BAN:JAN]', u'GR-20263', u'LY 139381', u'LY-139381', u'C22-H22-N6-O7-S2.5H2-O', u'1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-(1-carboxy-1-methylethyl)oxime), pentahydrate']
- (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
- (6R,7R)-7-[(3Z)-3-(2-aminothiazol-4-yl)-3-(2-hydroxy-1,1-dimethyl-2-oxo-ethoxy)imino-2-oxo-propyl]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- (6R,7R)-7-[(Z)-2-(Aminothiazol-4-yl)-2-(2-carboxypropoxyimino)acetamido]-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylate
- 1-(((6R,7R)-7-(((2Z)-(2-Amino-4-Thiazolyl)((1-Carboxy-1-Methylethoxy)Imino) Acetyl) Amino)-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo(4.2.0) Oct-2-En-3-Yl)Methyl)Pyridinum Hydroxide Inner Salt
- Biotum
- Cefazid
- Ceftacidin
- Ceftazidim
- Mehr Synonyme anzeigen
- Ceftazidima
- Ceftazidime anhydrous
- Ceftazidine
- Fortam
- Fortaz
- Fortum
- Gr 20263
- Modacin
- Pyridinium, 1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt
- Pyridinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt
- Pyridinium, 1-[[7-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, hydroxide, inner salt, [6R-[6α,7β(Z)]]-
- Solvetan
- Tazicef
- Tazid
- Tazidime
- Tizime
- Zidim
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Indagoo
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
546.5761
Formel:
C22H22N6O7S2
Reinheit:
98%
Farbe/Form:
Solid
InChl:
InChI=1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1
InChI Key:
ORFOPKXBNMVMKC-DWVKKRMSSA-N
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code: